COMPANY
AURO PEPTIDES LTD
AURO PEPTIDES LTD: API manufacturer for Calcitonin, Degarelix, Desmopressin, Etelcalcetide, Ganirelix, Icatibant, Leuprolide, Linaclotide, Liraglutide, Octreotide, Plecanatide, Semaglutide, Teriparatide, Vasopressin, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Calcitonin | DMF 35791, type II, active, submitted 2021-03-30 Regulator FDA drug master file list |
|---|---|
| Degarelix | DMF 35078, type II, active, submitted 2020-08-07 Regulator FDA drug master file list |
| Desmopressin | DMF 30233, type II, active, submitted 2016-02-19 Regulator FDA drug master file list |
| Etelcalcetide | DMF 35386, type II, active, submitted 2020-11-12 Regulator FDA drug master file list |
| Ganirelix | DMF 36108, type II, active, submitted 2021-07-14 Regulator FDA drug master file list |
| Icatibant | DMF 33750, type II, active, submitted 2019-04-03 Regulator FDA drug master file list |
| Leuprolide | DMF 31170, type II, active, submitted 2016-11-30 Regulator FDA drug master file list |
| Linaclotide | DMF 29708, type II, active, submitted 2015-09-22 Regulator FDA drug master file list |
| Liraglutide | DMF 37793, type II, active, submitted 2023-01-27 Regulator FDA drug master file list |
| Octreotide | DMF 29448, type II, active, submitted 2015-06-20 Regulator FDA drug master file list |
| Plecanatide | DMF 36321, type II, active, submitted 2021-09-24 Regulator FDA drug master file list |
| Semaglutide | DMF 42442, type II, active, submitted 2026-03-06 Regulator FDA drug master file list |
| Teriparatide | DMF 33079, type II, active, submitted 2018-08-17 Regulator FDA drug master file list |
| Vasopressin | DMF 33119, type II, active, submitted 2018-08-27 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.